Get our Free Patent Expiration Newsletter

Serving leading biopharmaceutical companies globally:

Mallinckrodt
McKinsey
Boehringer Ingelheim
Medtronic
Colorcon
Merck

Last Updated: October 21, 2019

DrugPatentWatch Database Preview

CLINICAL TRIALS PROFILE FOR MIDODRINE HYDROCHLORIDE

See Plans and Pricing

« Back to Dashboard

Clinical Trials for Midodrine Hydrochloride

Trial ID Title Status Sponsor Phase Start Date Summary
NCT00004268 Phase II Study of Midodrine for Neurogenic Orthostatic Hypotension Completed Roberts Pharmaceutical Phase 2 2001-04-01 OBJECTIVES: I. Study further the safety and efficacy of the alpha-receptor agonist midodrine in patients with neurogenic orthostatic hypotension. II. Assess the quality of life in these patients with this treatment regimen.
NCT00004268 Phase II Study of Midodrine for Neurogenic Orthostatic Hypotension Completed National Center for Research Resources (NCRR) Phase 2 2001-04-01 OBJECTIVES: I. Study further the safety and efficacy of the alpha-receptor agonist midodrine in patients with neurogenic orthostatic hypotension. II. Assess the quality of life in these patients with this treatment regimen.
NCT00004479 Randomized Study of Midodrine, an Alpha Adrenergic Agonist, in Patients With Neurally Mediated Syncope Completed Icahn School of Medicine at Mount Sinai N/A 1999-03-01 OBJECTIVES: Determine the efficacy of midodrine, a selective alpha 1 adrenergic agonist, in preventing neurally mediated syncope.
>Trial ID >Title >Status >Phase >Start Date >Summary

Clinical Trial Conditions for Midodrine Hydrochloride

Condition Name

Condition Name for Midodrine Hydrochloride
Intervention Trials
Orthostatic Hypotension 9
Cirrhosis 7
Hypotension 5
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Condition MeSH

Condition MeSH for Midodrine Hydrochloride
Intervention Trials
Hypotension 28
Hypotension, Orthostatic 22
Hepatorenal Syndrome 9
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Locations for Midodrine Hydrochloride

Trials by Country

Trials by Country for Midodrine Hydrochloride
Location Trials
United States 169
Canada 23
Australia 6
New Zealand 4
India 4
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Trials by US State

Trials by US State for Midodrine Hydrochloride
Location Trials
New York 21
Tennessee 10
Texas 9
Ohio 8
Florida 8
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Progress for Midodrine Hydrochloride

Clinical Trial Phase

Clinical Trial Phase for Midodrine Hydrochloride
Clinical Trial Phase Trials
Phase 4 17
Phase 3 12
Phase 2/Phase 3 4
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Status

Clinical Trial Status for Midodrine Hydrochloride
Clinical Trial Phase Trials
Completed 28
Recruiting 21
Not yet recruiting 10
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Sponsors for Midodrine Hydrochloride

Sponsor Name

Sponsor Name for Midodrine Hydrochloride
Sponsor Trials
James J. Peters Veterans Affairs Medical Center 7
Chelsea Therapeutics 6
Shire 5
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Sponsor Type

Sponsor Type for Midodrine Hydrochloride
Sponsor Trials
Other 57
Industry 20
U.S. Fed 11
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Moodys
Boehringer Ingelheim
Harvard Business School
AstraZeneca
Baxter
Dow

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.